The evidence-based clinical practice guidelines for liver cirrhosis (LC) from the Japanese Society of Gastroenterology (JSGE)/ JSH published in 2020 reflect three criteria for initiating nutritional therapy: hypoalbuminemia (serum albumin <  3.5 g/dL), Child–Pugh grade B or C, or sarcopenia [12,13]. Here, ALB is linked to sarcopenia.